These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Enzyme-inhibiting factor in subacute necrotizing encephalomyelopathy. Pincus JH; Itokawa Y; Cooper JR Neurology; 1969 Sep; 19(9):841-5. PubMed ID: 5816876 [No Abstract] [Full Text] [Related]
6. Specificity of the urine inhibitor test for Leigh's disease. Pincus JH; Cooper JR; Piros K; Turner V Neurology; 1974 Sep; 24(9):885-90. PubMed ID: 4859485 [No Abstract] [Full Text] [Related]
8. An autosomal dominant form of necrotizing encephalomyelopathy resembling a spinocerebellar degeneration. Greenwood RS; DeVivo DC; Nelson JS; Dodson WE; Raichle ME; Gado M; Haymond MW; Prensky AL Trans Am Neurol Assoc; 1975; 100():47-51. PubMed ID: 1226640 [No Abstract] [Full Text] [Related]
16. Subacute necrotizing encephalomyelopathy (Leigh's disease): a consideration of clinical features and etiology. Pincus JH Dev Med Child Neurol; 1972 Feb; 14(1):87-101. PubMed ID: 4554097 [No Abstract] [Full Text] [Related]
17. Biochemical studies and therapy in subacute necrotizing encephalomyelopathy (Leigh's syndrome). Grover WD; Auerbach VH; Patel MS J Pediatr; 1972 Jul; 81(1):39-44. PubMed ID: 4556192 [No Abstract] [Full Text] [Related]
18. Leigh's disease in an adult with evidence of "inhibitor factor" in family members. Whetsell WO; Plaitakis A Ann Neurol; 1978 Jun; 3(6):519-24. PubMed ID: 209725 [TBL] [Abstract][Full Text] [Related]